Form 6-K BioLineRx Ltd. For: Mar 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
BioLineRx (BLRX) PT Lowered to $2 at Maxim Group
March 6, 2018 1:21 PM ESTMaxim Group lowered its price target on BioLineRx (NASDAQ: BLRX) to $2.00 (from $3.00) while maintaining a Buy rating.
Analyst Jason McCarthy commented, "BiolineRx reported 4Q17 with a net loss of $7.4M and ended the period with $50M in cash on the balance sheet,... More
